Phase 4CompletedINTERVENTIONAL
Single Dose of Vyleesi in Lactating Female Subjects to Measure the Concentration of Bremelanotide in Breast Milk
ClinicalTrials.gov · NCT06867835 · Registry updated: 2026-01-13
- Condition / research focus
- Lactating Mother
- Sponsor
- Cosette Pharmaceuticals, Inc.
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2025-07-11. Completion: 2025-11-15 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Vyleesi (Bremelanotide Injection) (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- First Excellence Research Group LLC
Doral, Florida, United States
Site recruitment: Not reported